4th LNP Immunogenicity & Toxicity Digital Summit
Conference Details
Date: 03 December 2025
Time: 08:30
Duration: 1 day
Location: Online
Cost: $ 1119 - $ 1919
Organiser: Hanson Wade
Conference Description
Assessing LNP Immunogenicity & Toxicity to Effectively Monitor Clinical Safety & Ensure Regulatory Compliance for Novel Therapeutics & Vaccines
Achieve Superior LNP Patient Safety Profiles for Your Cargo at the 4th LNP Immunogenicity & Toxicity Digital Summit
Recent success of LNP safety has put the industry back in the spotlight. From personalized CRISPR treatments and Capstan’s phase I trial initiation for autoimmune diseases, to Verve’s recent clinical progress to lower cholesterol; these headlines have reignited the hope for LNPs to solve the biggest hurdles in drug delivery.
The 4th LNP Immunogenicity & Toxicity Summit returns in December, as an industry-dedicated virtual forum, bringing you the key updates on pre-clinical and clinical safety assessments and assays to effectively measure and monitor LNP safety for gene and cell therapies and vaccine applications.
This year’s exclusive one-day program will provide you with an entire day of scientific progress and technical insights into LNP mechanism of action, translational animal model approaches, and pharmacokinetic and dynamic studies to support the prediction, dosing strategy, and improve clinical effectiveness of pegylated and ionizable LNPs across all payloads.
Log on to the platform from the comfort or your home or office and connect with 80+ fellow LNP experts spanning non-clinical and clinical safety, from immunology, toxicology, pharmacology, and bioanalytics to learn, share, and network virtually to support the development of safer LNPs for patients faster.
© EuroJobsites 2025